Multisite study of the relationships between antemortem [ 11 C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology-Reference-Cited by-同舟云学术

Multisite study of the relationships between antemortem [ 11 C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

Published:2018-10-19 Issue:2 Volume:15 Page:205-216
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

La Joie Renaud¹,Ayakta Nagehan¹²,Seeley William W.¹,Borys Ewa³,Boxer Adam L.¹,DeCarli Charles⁴,Doré Vincent⁵,Grinberg Lea T.¹,Huang Eric¹,Hwang Ji‐Hye¹,Ikonomovic Milos D.⁶⁷,Jack Clifford⁸,Jagust William J.²,Jin Lee‐Way⁹,Klunk William E.⁶⁷¹⁰,Kofler Julia¹¹,Lesman‐Segev Orit H.¹,Lockhart Samuel N.²¹²,Lowe Val J.¹³,Masters Colin L.¹⁴,Mathis Chester A.¹⁵,McLean Catriona L.¹⁶,Miller Bruce L.¹,Mungas Daniel⁴,O'Neil James P.²¹⁷,Olichney John M.⁴,Parisi Joseph E.¹⁸¹⁹,Petersen Ronald C.¹,Rosen Howard J.¹,Rowe Christopher C.⁵,Spina Salvatore¹,Vemuri Prashanthi⁸,Villemagne Victor L.⁵¹⁴,Murray Melissa E.²⁰,Rabinovici Gil D.¹²

Affiliation:

1. Memory & Aging CenterDepartment of NeurologyUniversity of CaliforniaSan FranciscoCAUSA

2. Helen Wills Neuroscience InstituteUniversity of California BerkeleyCAUSA

3. Department of PathologyStritch School of MedicineLoyola UniversityMaywoodILUSA

4. Department of NeurologyUniversity of CaliforniaDavisCAUSA

5. Department of Molecular Imaging & TherapyCentre for PETAustin HealthHeidelbergVictoriaAustralia

6. Department of NeurologyUniversity of PittsburghPAUSA

7. Department of PsychiatryUniversity of PittsburghPAUSA

8. Department of RadiologyMayo ClinicRochesterMNUSA

9. Alzheimer's Disease CenterDepartment of PathologyUniversity of California DavisCAUSA

10. Alzheimer's Disease Research CenterUniversity of PittsburghPAUSA

11. Department of PathologyUniversity of PittsburghPennsylvaniaUSA

12. Department of Internal MedicineDivision of Gerontology and Geriatric MedicineWake Forest School of MedicineWinston‐SalemNCUSA

13. Department of Nuclear MedicineMayo ClinicRochesterMNUSA

14. The Florey InstituteThe University of MelbourneMelbourneVictoriaAustralia

15. Department of RadiologyUniversity of PittsburghPAUSA

16. Department of Anatomical PathologyAlfred HospitalMelbourneAustralia

17. Biomedical Isotope FacilityMBIB DivisionLawrence Berkeley National LaboratoryCAUSA

18. Department of Laboratory Medicine and PathologyMayo ClinicRochesterMNUSA

19. Department of NeurologyMayo ClinicRochesterMNUSA

20. Department of NeuroscienceMayo ClinicJacksonvilleFLUSA

Funder

Biogen

Genentech

GE Healthcare

National Institutes of Health

National Institute on Aging

National Cancer Institute

National Institute of Health

Mayo Foundation

Eli Lilly

GlaxoSmithKline

NIH

Roche, Inc

Merck, Inc.

Genentech, Inc.

Biogen, Inc

Merck

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.09.001

Reference44 articles.

1. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

2. Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers

3. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association;Johnson KA;Alzheimers Dement J Alzheimers Assoc,2013

4. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation

5. Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals;Alzheimer's & Dementia;2024-01-24

2. Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias;Alzheimer's & Dementia;2024-01-15

3. Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01

4. PET imagining in Alzheimer’s disease;Ukrainian Journal of Military Medicine;2023-12-29

5. A Case-Control Clinical Trial on a Deep Learning-Based Classification System for Diagnosis of Amyloid-Positive Alzheimer’s Disease;Psychiatry Investigation;2023-12-25